Research Article
Increased Frequency of CD4+ CD25+ FoxP3+ T Regulatory Cells in Pulmonary Tuberculosis Patients Undergoing Specific Treatment and Its Relationship with Their Immune-Endocrine Profile
Table 2
Cytokine and hormone levels in TB patients during specific treatment.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comparisons between groups. HCo versus T0, , versus T2, ; bHCo versus T0, , versus T2, , versus T4, ; cHCo versus T0, ; dHCo versus T0, , versus T2, ; eHCo versus T0, , versus T2, , versus T4, , versus T6, . Comparisons within TB patients. T0 versus T2, T4, T6, T9, ; T0 versus T2, T4, T6, T9, ; T0 versus T2, T4, T6, T9, ; T0 versus T9, ; T0 versus T9, . Results are shown as median values (25–75 percentiles). HCo: healthy controls. T0: time of diagnosis; T2, T4, T6: 2, 4, and 6 months after starting the specific anti-TB treatment; T9: 3 months after the end treatment completion. Comparisons for independent groups were made by the Kruskall-Wallis analysis of variance followed by post hoc test when applicable. Comparisons for related samples were performed by the Friedman analysis for variance. |